Get started
Source

Personalized Psychiatry and Neurology

ISSN: 2712-9179
Source type: journal
Publisher:
Fully OA: No
DOAJ: No
OpenAlex ID: S4210240758
Phase I of Antipsychotics Metabolism and its Pharmacogenetic Testing
2022 · N. A. Shnayder, A. K. Abdyrakhmanova, et al. · Personalized Psychiatry and Neurology · 13
PDF
Pharmacogenetics of chlorpromazine and its role in the development of antipsychotic-induced parkinsonism
2021 · E. E. Vaiman, M. A. Novitsky, et al. · Personalized Psychiatry and Neurology · 11
PDF
Role of Pharmacokinetics and Pharmacogenetics of Antidepressant-Induced Prolongation of the QT Interval and Torsade de Pointes in Patients with Mental Disorders
2023 · N. A. Shnayder, A. V. Kidyaeva, et al. · Personalized Psychiatry and Neurology · 9
PDF
A paradigm shift to treat psychoneurological disorders
2021 · Н. Г. Незнанов · Personalized Psychiatry and Neurology · 9
Personalized approach to antipsychotic-induced weight gain prognosis
2021 · Vera S. Dobrodeeva, Aiperi K. Abdyrahmanova, et al. · Personalized Psychiatry and Neurology · 9
PDF
From Classical to Personalized Psychoneurology
2022 · N. G. Neznanov, R. F. Nasyrova, et al. · Personalized Psychiatry and Neurology · 8
PDF
Clinical Case of a 36-year-old Patient with Paranoid Schizophrenia and Drug-Induced QT Prolongation
2022 · N. M. Zhuravlev, A. P. Otmachov, et al. · Personalized Psychiatry and Neurology · 7
PDF
Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk
2022 · N. M. Zhuravlev, N. A. Shnayder, et al. · Personalized Psychiatry and Neurology · 7
PDF
The role of NO system in low back pain chronicity
2021 · V. V. Trefilova, N. A. Shnayder, et al. · Personalized Psychiatry and Neurology · 7
PDF
Neuroinflammation as an Integral Component of Neurodegeneration in Parkinson's Disease
2024 · Z. F. Sayfitdinkhuzhaev, N. G. Zhukova, et al. · Personalized Psychiatry and Neurology · 6
PDF
The Role of Pharmacogenetic Testing in Optimizing Antipsychotic Therapy
2024 · A. P. Otmakhov, D. S. Proydina, et al. · Personalized Psychiatry and Neurology · 6
PDF
Pharmacogenetic Factors of Clozapine-Induced Metabolic Syndrome
2023 · A. K. Khasanova · Personalized Psychiatry and Neurology · 6
PDF
Pharmacogenetic Testing of Cytochrome P450 Metabolizing Enzymes in 28-Year-Old Man with Treatment-Resistant Schizophrenia
2022 · A. K. Abdyrakhmanova, R. F. Nasyrova · Personalized Psychiatry and Neurology · 6
PDF
Candidate genes and single-nucleotide gene variants associated with muscle and tendon injuries in cyclic sports athletes
2021 · O. V. Balberova · Personalized Psychiatry and Neurology · 6
PDF
Frequency of "Poor Transporter" Phenotype Among Patients with Mental Disorders: Pilot Study
2024 · I. R. Boyko, N. A. Shnayder, et al. · Personalized Psychiatry and Neurology · 5
PDF
"Multiomic" Studies as a Promising Clinical Pharmacological Tool for Personalization of Socially Significant Diseases Pharmacotherapy in Russia
2022 · D. A. Sychev · Personalized Psychiatry and Neurology · 5
PDF
Pharmacogenetic Testing of Antipsychotic Transporter Proteins: A Case Report in a 32-Year-Old Woman with Treatment-Resistant Schizophrenia
2022 · S M. Osipova, N. S. Shnayder · Personalized Psychiatry and Neurology · 5
PDF
Personalized Psychiatry and Neurology
2021 · Personalized Psychiatry and Neurology · 5
Modern Psychiatry: from Theory to Practice
2024 · N. N. Petrova · Personalized Psychiatry and Neurology · 4
PDF
Hematological Predictors of Antipsychotic-induced Metabolic Syndrome in a Female Patient with Schizophrenia: Case Report
2024 · R. F. Nasyrova, A. V. Kidyaeva, et al. · Personalized Psychiatry and Neurology · 4
PDF
Antipsychotic-Induced Parkinsonism and Dyskinesia in a 43- years Old Male with Schizophrenia: Clinical Case
2023 · E. E. Vaiman, L. P. Linova · Personalized Psychiatry and Neurology · 4
PDF
Epidemiology of Amyotrophic Lateral Sclerosis
2022 · P. S. Goncharova, T. K. Davidova, et al. · Personalized Psychiatry and Neurology · 4
PDF
Candidate genes associated with athletes' skeletal muscle functions regulation
2021 · O. V. Balberova, E. V. Bykov, et al. · Personalized Psychiatry and Neurology · 4
PDF
Morphometric Characteristics of Cerebral Structures in Gilles De La Tourette Syndrome
2025 · D. A. Nurmatova, N. G. Zhukova, et al. · Personalized Psychiatry and Neurology · 3
PDF
Neuroprotective Activity of GLP-1 Analogues: General Understanding of Implementation Mechanisms
2024 · E. L. Golovina, O. E. Vaizova, et al. · Personalized Psychiatry and Neurology · 3
PDF
Works count: 118
Citation count: 230
H-index: 7
I10-index: 2
2yr mean citedness: 0.927
Year
Topic
Type